BackOlema Pharmaceuticals Overview
Olema Pharmaceuticals Inc

Olema Pharmaceuticals Target Price

See Olema Pharmaceuticals's analyst price targets ($35) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.51

Average Target Price

$35.00233% upside

1 analysts in the last 4 months

High: $35 | Low: $35

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-13Guggenheim$35233% upsideOpen
2026-03-09H.C. WainwrightEmily Bodnar$38261.6% upsideOpen
2026-02-10Stifel Nicolaus$48356.7% upsideOpen
2026-01-07Piper Sandler$40280.6% upsideOpen
2026-01-07UBSMichael Yee$45328.2% upsideOpen
2025-12-11Oppenheimer$48356.7% upsideOpen
2025-12-11Goldman Sachs$38261.6% upsideOpen
2025-12-11H.C. WainwrightEmily Bodnar$45328.2% upsideOpen
2025-12-10JefferiesMichael Yee$43309.1% upsideOpen
2025-11-21Goldman Sachs$26147.4% upsideOpen
2025-11-20Guggenheim$40280.6% upsideOpen
2025-11-18H.C. Wainwright$36242.5% upsideOpen
2025-10-20H.C. WainwrightEmily Bodnar$28166.4% upsideOpen
2025-10-08Guggenheim$2090.3% upsideOpen
2024-10-24Goldman SachsRichard Law$27156.9% upsideOpen
2024-05-16H.C. WainwrightEmily Bodnar$30185.4% upsideOpen
2024-04-02Goldman SachsRichard Law$24128.4% upsideOpen

Olema Pharmaceuticals (OLMA) FAQ

Olema Pharmaceuticals posts a target price of $35. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $35 for OLMA means covering analysts, on average, see the stock 233.0% upside of $10.51 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for OLMA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Olema Pharmaceuticals's other metric pages and overview cover the third.

Judging Olema Pharmaceuticals against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $35 here, then scan peer and history charts to see if the gap is persistent.